BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36415836)

  • 1. A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib.
    Bradt N; Olbrechts F; Alexander P; Salembier A
    Eur J Case Rep Intern Med; 2022; 9(10):003601. PubMed ID: 36415836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced chylothorax as a rare pleural complication in dasatinib therapy for chronic myeloid leukaemia.
    Ng IK; Ruparel M; Chan EH; Khoo KL
    J R Coll Physicians Edinb; 2024 Mar; 54(1):44-47. PubMed ID: 38486345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib-induced chylothorax: report of a case and review of the literature.
    Chen B; Wu Z; Wang Q; Li W; Cheng D
    Invest New Drugs; 2020 Oct; 38(5):1627-1632. PubMed ID: 32248338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
    Hsu CC; Hsu JF; Wu KL
    Respirol Case Rep; 2021 Jun; 9(6):e00753. PubMed ID: 33976882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib-associated chylothorax in a pediatric patient with chronic myeloid leukemia: a case report and literature review.
    Liu Q; Fu J; Zhang A
    Transl Cancer Res; 2023 Jan; 12(1):194-200. PubMed ID: 36760377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dasatinib-induced Chylothorax in Chronic Myeloid Leukemia.
    Alqattan Y; Ali S; Almohammad R; Kayali N; Alhuraiji A
    Gulf J Oncolog; 2022 Sep; 1(40):74-77. PubMed ID: 36448074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Pitfalls of Chylothorax After Dasatinib Treatment of Chronic Myeloid Leukemia.
    Kelly RL; Bae JY; D'Annunzio S; Montanari F
    Am J Case Rep; 2022 Nov; 23():e938319. PubMed ID: 36444127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dasatinib-Induced Chylothorax Beyond 5 Years of Treatment: Is There Actually Any Limit?
    Garcia-Zamalloa A; Basauri B; Urcelay G; Sainz A
    Eur J Case Rep Intern Med; 2023; 10(7):003921. PubMed ID: 37455693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia.
    Makimoto G; Misawa M; Maeda Y; Kiura K
    Respir Med Case Rep; 2022; 37():101662. PubMed ID: 35585905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Chylous Pleural Effusions in a Patient Treated With Dasatinib.
    Nasir SA; Calavia Liano H; Manfredi C
    Cureus; 2022 Aug; 14(8):e27778. PubMed ID: 36106302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dasatinib-induced chylothorax: An unusual presentation of a common adverse event-A case report with literature review.
    Paul T; Ellahie AY; Almohtasib YS; Sinha U; El Omri H
    EJHaem; 2021 Aug; 2(3):545-550. PubMed ID: 35844702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasatinib-Induced Chylothorax: A Clinical Laboratory's Perspective.
    Martínez RJG; Gea CS; Martin-Riera V; Ruiz ARG; Barzanti RP; Ferrer-Costa R; Ramirez-Serra C
    EJIFCC; 2023 Apr; 34(1):76-80. PubMed ID: 37124659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chylothorax: complication attributed to dasatinib use.
    Al-Abcha A; Iftikhar MH; Abu Rous F; Laird-Fick H
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31848139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases].
    Yang L; Lu N; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1348-1353. PubMed ID: 27784355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chylothorax with Transudate: An Unusual Presentation of Tuberculosis.
    Zamora-López MA; Farias-Navarro IC; Rendon-Ramirez EJ
    Eur J Case Rep Intern Med; 2020; 7(8):001645. PubMed ID: 32789131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature.
    Hickman K; Diaz E; Graham R; Adams R; Ngwube A
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e665-e667. PubMed ID: 31688632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Control of Dasatinib-related Chylothorax by the Japanese Herbal Medicine "Goreisan".
    Sasaki H; Kimizuka Y; Ogata H; Okada Y; Ota S; Sano T; Watanabe C; Maki Y; Yamamoto T; Tagami Y; Miyata J; Hayashi N; Fujikura Y; Kawana A
    Intern Med; 2019 Nov; 58(21):3139-3141. PubMed ID: 31292394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.
    Kaiafa G; Kakaletsis N; Savopoulos C; Perifanis V; Giannouli A; Papadopoulos N; Zisekas S; Hatzitolios AI
    J Clin Pharm Ther; 2014 Feb; 39(1):102-5. PubMed ID: 24188312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib-related chylothorax.
    Huang YM; Wang CH; Huang JS; Yeh KY; Lai CH; Wu TH; Chang PH; Chang PH; Chang YS; Lan YJ
    Turk J Haematol; 2015 Mar; 32(1):68-72. PubMed ID: 25805678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib-induced pleural effusion: Chylothorax, an option to consider.
    Ferreiro L; San-José E; Suárez-Antelo J; Valdés L
    Ann Thorac Med; 2016; 11(4):289-293. PubMed ID: 27803756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.